We discussed the research behind the FDAs announcement with Margaret McCarthy, PhD, an NAM member and neuroscientist studying early brain development at the University of Maryland
Need a Doctor
Expanding Applications: Clinical trials are actively investigating the use of GLP-1 RAs for a wider range of conditions, including addiction, kidney disease, and neurodegenerative disorders, based on their broad physiological effects
This powerful antioxidant directly participates in phase II detoxification processes, helping the liver process and eliminate toxins, medications, and metabolic waste products more effectively
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation
Benefits & Absorption Guide breaks it down clearly